MedTrace Logo

One-stage and Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography with Endoscopic Sphincterotomy in Cholecystocholedocholithiasis

NCT06676241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-03-10

No results posted yet for this study

Summary

In this study, it is planned to compare ERCP with ES + delayed LC in children, with one-stage LC + ERCP with ES in adults to confirm that ERCP with ES + delayed LC is more suitable for pediatric patients with cholecystocholedocholithiasis.

Conditions

  • Choledocholithiasis
  • Cholecystolithiasis
  • Cholangiopancreatography, Endoscopic Retrograde
  • Laparoscopic Cholecystectomy
  • Children
  • Acute Pancreatitis (AP)
  • Common Bile Duct Calculi

Interventions

PROCEDURE

endoscopic retrograde cholangiopancreatography; laparoscopic cholecystectomy

Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed immediately after ERCP with ES under general anesthesia.

PROCEDURE

endoscopic retrograde cholangiopancreatography;laparoscopic cholecystectomy

Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patient underwent the endoscopic procedure using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed on a delayed basis no earlier than 7 days after ERCP

Sponsors & Collaborators

  • Moscow Regional Research and Clinical Institute (MONIKI)

    lead OTHER_GOV

Principal Investigators

  • Dmitriy А Pyhteev, PhD · Head of the Department of Pediatric Surgery

  • Leonid M Elin · Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

Eligibility

Min Age
0 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-13
Primary Completion
2025-02-20
Completion
2025-03-05

Countries

  • Russia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06676241 on ClinicalTrials.gov